AIDS Research and Therapy BioMed Central Review Microbicides 2008 conference: From discovery to advocacy

[1]  L. Brown,et al.  Oxidant‐induced atrogin‐1 and transforming growth factor‐β1 precede alcohol‐related myopathy in rats , 2007, Muscle & nerve.

[2]  Holly McDonough,et al.  Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. , 2007, The Journal of clinical investigation.

[3]  Y. Zhu,et al.  Role of transforming growth factor-β in the progression of heart failure , 2006, Cellular and Molecular Life Sciences CMLS.

[4]  P. Razeghi,et al.  Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. , 2006, Biochemical and biophysical research communications.

[5]  P. Razeghi,et al.  Atrophic Remodeling of the Transplanted Rat Heart , 2006, Cardiology.

[6]  T. Akiyama,et al.  MFB‐1, an F‐box‐type ubiquitin ligase, regulates TGF‐β signalling , 2004 .

[7]  W. Stehbens.  Oxidative stress in viral hepatitis and AIDS. , 2004, Experimental and molecular pathology.

[8]  A. Goldberg,et al.  IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. , 2004, American journal of physiology. Endocrinology and metabolism.

[9]  M. Reitz,et al.  HIV-1 transgenic rats develop T cell abnormalities. , 2004, Virology.

[10]  G. Bárbaro.  Pathogenesis of HIV-associated heart disease , 2003, AIDS.

[11]  A. Samarel,et al.  Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. , 2002, American journal of physiology. Heart and circulatory physiology.

[12]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[14]  M. Reitz,et al.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Lewis.  Cardiomyopathy in AIDS: a pathophysiological perspective. , 2000, Progress in cardiovascular diseases.

[16]  L. Patrick.  Nutrients and HIV: part three - N-acetylcysteine, alpha-lipoic acid, L-glutamine, and L-carnitine. , 2000, Alternative medicine review : a journal of clinical therapeutic.

[17]  I. Lundberg.  The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies , 2000, Current rheumatology reports.

[18]  D. Wilmore,et al.  Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. , 1999, Nutrition.

[19]  S. Arver,et al.  Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Agell,et al.  Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. , 1998, International journal of molecular medicine.

[21]  M. Schluchter,et al.  Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. , 1998, Circulation.

[22]  W. Dröge,et al.  Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Y. Lévy,et al.  Muscle involvement in human immunodeficiency virus‐infected patients is associated with marked selenium deficiency , 1997, Muscle & nerve.

[24]  V. Hack,et al.  Cystine levels, cystine flux, and protein catabolism in cancer cachexia, HIV/SIV infection, and senescence , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  S. De Castro,et al.  Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. , 1994, Journal of the American College of Cardiology.

[26]  L. Bélec,et al.  The slim disease in African patients with AIDS. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[27]  W. Grody,et al.  Infection of the heart by the human immunodeficiency virus. , 1990, The American journal of cardiology.

[28]  G. Hensley,et al.  Pathology of the heart in acquired immunodeficiency syndrome. , 1987, Archives of pathology & laboratory medicine.

[29]  P. Muñoz-Cánoves,et al.  HIV-1 transgenic expression in mice induces selective atrophy of fast-glycolytic skeletal muscle fibers. , 2008, Frontiers in bioscience : a journal and virtual library.

[30]  Y. Zhu,et al.  Role of transforming growth factor-beta in the progression of heart failure. , 2006, Cellular and molecular life sciences : CMLS.

[31]  H. Kan,et al.  iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes. , 2006, Journal of molecular and cellular cardiology.

[32]  K. Yarasheski,et al.  Reducing plasma HIV RNA improves muscle amino acid metabolism. , 2005, American journal of physiology. Endocrinology and metabolism.

[33]  H. Kan,et al.  p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes. , 2004, American journal of physiology. Cell physiology.

[34]  T. Akiyama,et al.  MFB-1, an F-box-type ubiquitin ligase, regulates TGF-beta signalling. , 2004, Genes to cells : devoted to molecular & cellular mechanisms.